WHO Warns of ‘Humanitarian Catastrophe’ as it Releases $3.5 Million in Aid to Ukraine 25/02/2022 Maayan Hoffman & Elaine Ruth Fletcher The World Health Organization said it had released $3.5 million to support delivery of urgent medical supplies to the people of Ukraine, after Russia invaded the country on three fronts simultaneously early Thursday morning. Meanwhile, WHO’s European Regional Office called for an end to hostilities saying: “any further escalation could result in a humanitarian catastrophe […] Continue reading -> Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> One COVID Vaccine Jab After Recovery Cut Risk of Reinfection by Delta Variant Up to 82% 18/02/2022 Maayan Hoffman Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading -> BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> Two Years into COVID Pandemic, 92 % of Countries Still Face Significant Health Service Disruptions 08/02/2022 Maayan Hoffman Two years after the COVID-19 pandemic began, over ninety percent of countries continue to face ongoing disruptions to their health systems, according to a survey published Monday evening by the World Health Organization. The WHO Global Pulse Survey, the third of its kind since the start of the COVID-19 crisis, analysed responses from 129 countries, […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Long COVID: Researchers Find ‘Antibody Signature’ to Identify High-Risk Patients; Two Vaccine Shots Could Stop the Syndrome 31/01/2022 Maayan Hoffman Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Novel AstraZeneca ‘Vaccine’ for Immunosuppressed Offers ‘Passive Immunization’ with Antibody Cocktail 20/02/2022 Maayan Hoffman Immunosuppressed individuals living in the United States and Israel have been among the first to receive a novel new “vaccine” that preventively boosts their defenses against COVID-19 infection with a cocktail of long-acting antibodies. The vaccine by AstraZeneca, branded as Evusheld, works on the principle of “passive immunization”, and contains two long-acting monoclonal antibodies (tixagevimab […] Continue reading -> One COVID Vaccine Jab After Recovery Cut Risk of Reinfection by Delta Variant Up to 82% 18/02/2022 Maayan Hoffman Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading -> BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> Two Years into COVID Pandemic, 92 % of Countries Still Face Significant Health Service Disruptions 08/02/2022 Maayan Hoffman Two years after the COVID-19 pandemic began, over ninety percent of countries continue to face ongoing disruptions to their health systems, according to a survey published Monday evening by the World Health Organization. The WHO Global Pulse Survey, the third of its kind since the start of the COVID-19 crisis, analysed responses from 129 countries, […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Long COVID: Researchers Find ‘Antibody Signature’ to Identify High-Risk Patients; Two Vaccine Shots Could Stop the Syndrome 31/01/2022 Maayan Hoffman Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
One COVID Vaccine Jab After Recovery Cut Risk of Reinfection by Delta Variant Up to 82% 18/02/2022 Maayan Hoffman Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading -> BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> Two Years into COVID Pandemic, 92 % of Countries Still Face Significant Health Service Disruptions 08/02/2022 Maayan Hoffman Two years after the COVID-19 pandemic began, over ninety percent of countries continue to face ongoing disruptions to their health systems, according to a survey published Monday evening by the World Health Organization. The WHO Global Pulse Survey, the third of its kind since the start of the COVID-19 crisis, analysed responses from 129 countries, […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Long COVID: Researchers Find ‘Antibody Signature’ to Identify High-Risk Patients; Two Vaccine Shots Could Stop the Syndrome 31/01/2022 Maayan Hoffman Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
BA.2 Now Dominant in South Africa: Could New ‘Stealth’ Sub-Variant Delay Hoped-For Pandemic Reprieve? 11/02/2022 Maayan Hoffman The BA.2 sub-variant of Omicron is now the dominant COVID-19 variant in South Africa, the head of Africa’s Centers for Disease Control and Prevention (CDC) confirmed on Thursday – raising questions about whether the continued global creep of the new SARS-CoV2 sub-variant could dash hopes of a much-needed COVID-19 reprieve. “We have data from South […] Continue reading -> Two Years into COVID Pandemic, 92 % of Countries Still Face Significant Health Service Disruptions 08/02/2022 Maayan Hoffman Two years after the COVID-19 pandemic began, over ninety percent of countries continue to face ongoing disruptions to their health systems, according to a survey published Monday evening by the World Health Organization. The WHO Global Pulse Survey, the third of its kind since the start of the COVID-19 crisis, analysed responses from 129 countries, […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Long COVID: Researchers Find ‘Antibody Signature’ to Identify High-Risk Patients; Two Vaccine Shots Could Stop the Syndrome 31/01/2022 Maayan Hoffman Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Two Years into COVID Pandemic, 92 % of Countries Still Face Significant Health Service Disruptions 08/02/2022 Maayan Hoffman Two years after the COVID-19 pandemic began, over ninety percent of countries continue to face ongoing disruptions to their health systems, according to a survey published Monday evening by the World Health Organization. The WHO Global Pulse Survey, the third of its kind since the start of the COVID-19 crisis, analysed responses from 129 countries, […] Continue reading -> New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Long COVID: Researchers Find ‘Antibody Signature’ to Identify High-Risk Patients; Two Vaccine Shots Could Stop the Syndrome 31/01/2022 Maayan Hoffman Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Study Shows Correlation Between Vitamin D Deficiency and Severe COVID 07/02/2022 Maayan Hoffman Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Long COVID: Researchers Find ‘Antibody Signature’ to Identify High-Risk Patients; Two Vaccine Shots Could Stop the Syndrome 31/01/2022 Maayan Hoffman Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Long COVID: Researchers Find ‘Antibody Signature’ to Identify High-Risk Patients; Two Vaccine Shots Could Stop the Syndrome 31/01/2022 Maayan Hoffman Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Long COVID: Researchers Find ‘Antibody Signature’ to Identify High-Risk Patients; Two Vaccine Shots Could Stop the Syndrome 31/01/2022 Maayan Hoffman Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Long COVID: Researchers Find ‘Antibody Signature’ to Identify High-Risk Patients; Two Vaccine Shots Could Stop the Syndrome 31/01/2022 Maayan Hoffman Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> Posts navigation Older postsNewer posts